Results
3
Stocks where the price continues to rise after more than a year of consistent gains.
3 companies
Cleo Diagnostics
Market Cap: AU$61.0m
A medical diagnostics and devices company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.
COV
AU$0.47
7D
33.8%
1Y
137.5%
Alterity Therapeutics
Market Cap: AU$59.9m
Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.
ATH
AU$0.009
7D
28.6%
1Y
80.0%
Nanollose
Market Cap: AU$9.1m
A biomaterials company, engages in the research and development, and promotion of microbial cellulose technologies in Australia.
NC6
AU$0.044
7D
29.4%
1Y
100.0%